Ademola, Ayoola http://orcid.org/0000-0002-8412-6246
Hildebrand, Kevin A.
Schneider, Prism S.
Mohtadi, Nicholas G. H.
White, Neil J.
Bosse, Michael J.
Garven, Alexandra
Walker, Richard E. A.
Sajobi, Tolulope T.
Funding for this research was provided by:
U.S. Department of Defense (OR160026)
Article History
Received: 16 October 2019
Accepted: 13 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: The ethics approvals for the trial were obtained from the Conjoint Health Research Ethics Board (CHREB) at the University of Calgary (REB 17–0609) and Institutional Review Board (IRB)/ Research Ethics Board (HSREB) of other participation sites. All Protocol modifications will be reported to IRBs/REBs, regulatory bodies and communicated to participating trial sites. In addition, we will obtain signed written consent from all participants before randomization in the study. On trial completion, the data will be migrated off the clinical trial data management platform and housed in research data archival service for a period appropriate to satisfy the regulatory and ethical requirements of the trial.
: Not applicable. The manuscript does not have any patient information or details.
: There is no completing interest in the trial, however, the funding for the trial was obtained from the US Department of Defense. The funding body does not have any other role in this trial.